Elevance Health Reports Director, Officer, and Compensation Changes

Ticker: ELV · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1156039

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

Related Tickers: ELV

TL;DR

Elevance Health (ELV) filed an 8-K detailing leadership changes and compensation updates.

AI Summary

Elevance Health, Inc. filed an 8-K on December 10, 2025, reporting changes related to its board of directors and officers, including the election of new directors and updates to compensatory arrangements. The filing also notes the company's former names, Anthem, Inc., WellPoint, Inc., and WellPoint Inc., with their respective name change dates.

Why It Matters

This filing provides insight into the leadership structure and executive compensation policies of Elevance Health, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing reports routine corporate governance changes and does not indicate any significant financial distress or operational issues.

Key Players & Entities

FAQ

What specific changes were made regarding directors or officers?

The 8-K filing indicates changes related to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and updates to compensatory arrangements for certain officers.

When was this 8-K report filed?

The report was filed on December 10, 2025.

What is the exact name of the company filing this report?

The exact name of the registrant is Elevance Health, Inc.

What are some of the former names of Elevance Health, Inc. mentioned in the filing?

The filing mentions former names including Anthem, Inc., WELLPOINT, INC, and WELLPOINT INC.

What is the company's state of incorporation and fiscal year end?

Elevance Health, Inc. is incorporated in Indiana and its fiscal year ends on December 31.

Filing Stats: 620 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-12-10 16:35:16

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit N o Exhibit 99.1 Press Release, dated December 10 , 2025, announcing the election of Amy W. Schulman to the Elevance Health, Inc. Board of Directors. 104 Cover Page Interactive Data File (embedded within the Inline XBRL doc) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 10th day of December, 2025. ELEVANCE HEALTH, INC. By: /s/ Kathleen S. Kiefer Name: Kathleen S. Kiefer Title: Chief Governance Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing